文献速递心力衰竭与心肌病

基因阳性亲属中扩张型心肌病的外显率

Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives.
PubMed 文献 · J Am Coll Cardiol · 2024-01-01

本研究在西班牙25个中心随访779例无DCM的基因阳性亲属,中位随访37.1个月,10.9%进展为DCM,发病率2.9/100人年。年龄较大、心电图异常、运动肌节基因变异、较低LVEF、较大LVEDD及LGE与DCM发生独立相关。

要点

  • 基因阳性亲属首次筛查阴性后约11%在中位3年内进展为DCM。
  • 心电图异常、较低LVEF、较大LVEDD及运动肌节基因变异提示更高风险。
  • CMR检出LGE是DCM发生的额外独立预测因素。

核心结论

  • 基因阳性亲属首次筛查阴性后约11%在中位37.1个月内进展为DCM。
  • 年龄较大、心电图异常、运动肌节基因变异、较低LVEF、较大LVEDD及LGE与DCM发生风险升高相关。

研究设计与样本

  • 研究纳入西班牙25个中心779例无DCM的基因阳性患者,年龄35.8±17.3岁,女性459例(59%),TTN变异367例(47%)。
  • 中位随访37.1个月(Q1-Q3:16.3-63.8个月),评估新发DCM诊断的外显率及相关因素。

主要发现

  • 随访期间85例(10.9%)发生DCM,发病率为2.9/100人年(95%CI:2.3-3.5/100人年)。
  • DCM外显率和发病年龄因基础基因分组不同而异(log-rank P=0.015和P<0.01)。
  • 多变量模型(排除CMR参数)中,年龄较大(每增1岁HR:1.02;95%CI:1.0-1.04)、心电图异常(HR:2.13;95%CI:1.38-3.29)、运动肌节基因变异(HR:1.92;95%CI:1.05-3.50)、较低LVEF(每增1% HR:0.86;95%CI:0.82-0.90)及较大LVEDD(每增1mm HR:1.10;95%CI:1.06-1.13)为DCM发生的独立预测因素。
  • 在完成CMR及LGE评估的360例(45%)中,LGE为DCM发生的额外独立预测因素(HR:2.52;95%CI:1.43-4.45)。

临床怎么用

  • 对基因阳性亲属首次筛查阴性后仍需定期随访,尤其合并年龄较大、心电图异常、较低LVEF或较大LVEDD者。
  • 运动肌节基因变异及CMR检出LGE可帮助识别DCM发生风险更高的基因阳性亲属。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Disease penetrance in genotype-positive (G+) relatives of families with dilated cardiomyopathy (DCM) and the characteristics associated with DCM onset in these individuals are unknown. OBJECTIVES: This study sought to determine the penetrance of new DCM diagnosis in G+ relatives and to identify factors associated with DCM development. METHODS: The authors evaluated 779 G+ patients (age 35.8 ± 17.3 years; 459 [59%] females; 367 [47%] with variants in TTN) without DCM followed at 25 Spanish centers. RESULTS: After a median follow-up of 37.1 months (Q1-Q3: 16.3-63.8 months), 85 individuals (10.9%) developed DCM (incidence rate of 2.9 per 100 person-years; 95% CI: 2.3-3.5 per 100 person-years). DCM penetrance and age at DCM onset was different according to underlying gene group (log-rank P = 0.015 and P <0.01, respectively). In a multivariable model excluding CMR parameters, independent predictors of DCM development were: older age (HR per 1-year increase: 1.02; 95% CI: 1.0-1.04), an abnormal electrocardiogram (HR: 2.13; 95% CI: 1.38-3.29); presence of variants in motor sarcomeric genes (HR: 1.92; 95% CI: 1.05-3.50); lower left ventricular ejection fraction (HR per 1% increase: 0.86; 95% CI: 0.82-0.90) and larger left ventricular end-diastolic diameter (HR per 1-mm increase: 1.10; 95% CI: 1.06-1.13). Multivariable analysis in individuals with cardiac magnetic resonance and late gadolinium enhancement assessment (n = 360, 45%) identified late gadolinium enhancement as an additional independent predictor of DCM development (HR: 2.52; 95% CI: 1.43-4.45). CONCLUSIONS: Following a first negative screening, approximately 11% of G+ relatives developed DCM during a median follow-up of 3 years. Older age, an abnormal electrocardiogram, lower left ventricular ejection fraction, increased left ventricular end-diastolic diameter, motor sarcomeric genetic variants, and late gadolinium enhancement are associated with a higher risk of developing DCM.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Cabrera-Romero E, Ochoa JP, Barriales-Villa R, et al. Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives. J Am Coll Cardiol. 2024. PMID: 38658103. doi:10.1016/j.jacc.2024.02.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。